We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

SUBSCRIBE: Print / eNewsletter

Various Capitation Models Are Available for Oncology Networks

Nov 1, 1996
Volume: 
5
Issue: 
11

ORLANDO—Payers have an obligation to provide the best possible
oncology care, and the obligation is fulfilled "as a direct
result of having a managed network," said Christine Ngo,
capitation network manager for Blue Cross Blue Shield of Florida/Health
Options, Inc., Jacksonville. Further, she said, "the most
successful way we have found to develop a managed network is through capitation."

A Payer's Dream Network

Blue Cross Blue Shield of Florida/Health Options, Inc. began the
process of developing a capitated managed oncology network by
brainstorming about a "dream world" network, Christine Ngo
said in her presentation (see article).

Although recognizing the probable unfeasibility of such a "dream
world" due to individual market variations, the company
identified the three most desirable characteristics of their dream network:

  • Unlimited access for the plan's patients to any oncologist, radiation
    oncologist, and hospital in the network. Those participating would be
    the best physicians available and the most respected in their fields.

  • A variety of sophisticated information systems,
    available in each oncologist's office, to address utilization
    management, quality management, disease management, treatment
    protocols, quality of life, and patient and referring physician satisfaction.
  • Each oncologist, ideally, would have the ability to
    collect and analyze data in these areas, and produce reports on the results.
  • Coordination of care among the network doctors and
    all others who treat and interact with the plan's cancer patients,
    including primary care physicians, hospitals, home health agencies,
    hospice organizations, and the plan's own medical director.

Various levels of capitation are available, depending on the needs
and desires of both the payer and the oncology network. Speaking at a
managed oncology care conference organized by International Business
Communications, Ms. Ngo described five possible reimbursement methods.

Discounted fee-for-service (paying for each service performed,
but at a discounted rate). With this method, the payment structure is
usually already in place, so the status quo is not disturbed. On the
other hand, without a utilization management mechanism, the potential
for overutilization exists.

Even so, Ms. Ngo said, this is often a good interim step for a payer
to use with a new managed oncology network if the validity of the
available data is in question or the organizations can't agree upon a
rate. The payer, for instance, might start with this method for 6 to
12 months while both sides collect data to help them determine a fair
capitated rate.

Capitation with fee-for-service carve-outs, in which
professional services such as office visits are capitated but all
other services--inpatient admissions, chemotherapy, etc--are paid fee-for-service.

"The rationale for this approach is similar to that of straight
fee-for-service," Ms. Ngo said. "This method works well in
a market new to capitation or when the data are unsure. Remember,
though, that utilization is not being managed for those services that
continue to be paid fee-for-service."

Full professional capitation, in which all services, except
inpatient admissions, are capitated. This method poses a financial
risk for physicians because inpatient lengths of stay are difficult
to predict. However, the risk can be lessened by including a
stop-loss provision specifying that costs over an agreed-upon amount
will be shared.

Global capitation, in which all services, including inpatient
admissions, are capitated. This is especially risky for physicians
because of potential high-cost cases and the uncertainty of the level
of utilization. Another stumbling block, Ms. Ngo pointed out, is that
hospitals may balk at receiving payments directly from physicians.

Case rate payment, in which a lump sum payment is made for a
particular diagnosis. For example, a doctor treating a stage II
breast cancer patient would be paid a flat fee for that patient's
entire treatment, no matter what it involved. If the treatment
ultimately cost less than that amount, the doctor would keep the
extra money, but if the costs exceeded the payment, he or she would
have to absorb the loss.

"This, in my opinion, is the most sophisticated method and the
most managed alternative," Ms. Ngo said. "It is usually not
a good alternative, though, until the network is firmly established,
and benchmarks and average costs have been determined."

Direct or Third-Party Contracting

Payers can contract with managed oncology networks either directly or
through a third-party administrator, she said. Contracting through a
third-party administrator offers the advantages of sophisticated data
collection and analysis methodologies as well as certain economies of
scale if the third-party administrator operates in different
locations around the country.

Ms. Ngo pointed out, however, that some physicians are resistant to
dealing with a third party. Contracting directly with a group of
oncologists eliminates the intermediary and can be the best choice
when the physicians are a cohesive group.

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

Oncology Vol 32 No 4
Apr 15, 2018 Vol 32 No 4
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.